Drug intelligence / Profile preview

ProstaThrive

Development stage: Preclinical
Lead developer: OptiMale Labs
Modality: Small Molecules
Administration: Oral

Overview

ProstaThrive is a multi-ingredient dietary supplement formulated to address lower urinary tract symptoms (LUTS) and support prostate health in men. It is primarily indicated for conditions such as benign prostatic hyperplasia (BPH) and associated erectile dysfunction. The supplement's efficacy was evaluated in a 90-day, randomized, triple-blind, placebo-controlled clinical trial (NCT06504472) involving men aged 40 and older. The study focused on endpoints such as urinary urgency, nighttime urination frequency (nocturia), perceived urinary flow, and bladder emptying, as well as secondary outcomes related to sexual function and performance.

Brand names: ProstaThrive
Other names: ProstaThrive supplement

Beyond the preview

Go deeper on ProstaThrive.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProstaThrive.

Explore the full profile